A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model-Reference-Cited by-同舟云学术

A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model

Published:2018-06 Issue: Volume:9 Page:203-210
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Hu Junhui,Schokrpur Shiruyeh,Archang Maani,Hermann Kip,Sharrow Allison C.,Khanna Prateek,Novak Jesse,Signoretti Sabina,Bhatt Rupal S.,Knudsen Beatrice S.,Xu Hua,Wu Lily

Funder

UCLA/Caltech Medical Scientist Training Program

UCLA Tumour Immunology Training

Tumour Immunology Training

Virology and Gene Therapy

Cancer Research Coordinating Committee

NIH/NCI

NIH

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference25 articles.

1. Mouse models of cancer;Cheon;Annu. Rev. Pathol.,2011

2. CRISPR-Cas9 knockin mice for genome editing and cancer modeling;Platt;Cell,2014

3. CRISPR-mediated direct mutation of cancer genes in the mouse liver;Xue;Nature,2014

4. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis;Chen;Cell,2015

5. Rapid modelling of cooperating genetic events in cancer through somatic genome editing;Sánchez-Rivera;Nature,2014

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced gene therapy system for the treatment of solid tumour: A review;Materials Today Bio;2024-08

2. Challenges for gene editing in common variable immunodeficiency disorders: Current and future prospects;Clinical Immunology;2024-01

3. Vascular endothelial profilin-1 drives a protumorigenic tumor microenvironment and tumor progression in renal cancer;Journal of Biological Chemistry;2023-08

4. How CRISPR Is Revolutionizing the Generation of New Models for Cancer Research;Cold Spring Harbor Perspectives in Medicine;2023-07-24

5. Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma;Signal Transduction and Targeted Therapy;2023-04-17